All stock lists
eToro Group Ltd. (NASDAQ:ETOR)
IL · Delayed Price · Currency is USD
Financial Services · Financial - Capital Markets
23.38-0.55 (-2.28%)
Market cap
$1.89B
Health Score
Analyst consensus
Listed since
May 14, 2025
Website
Insider Score
––Not scored
ETOR Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ETOR analyst forecast
ETOR analyst consensus
Moderate Buy11 ratings
Buy 8 Hold 3 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
ETOR 12-month price target
$44.00+87.7% upsideaverage of 6 firms
$53.00High
$35.00Low
Best analysts covering ETOR
- Canaccord Genuity0%success rate · 3 calls
- Needham0%success rate · 2 calls
- Mizuho0%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ETOR analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Needham | Buy | — | — | Reiterated | 2026-10-21 |
| Canaccord Genuity | Buy | $47.00 | +94.9% | Reiterated | 2026-10-19 | |
| — | Keybanc | Overweight | — | — | Reiterated | 2026-10-16 |
| KeyBanc | — | $40.00 | +60.7% | — | 2026-10-16 | |
| Susquehanna | Positive | $46.00 | +83.8% | Reiterated | 2026-10-13 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-12 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-10-09 |
| Mizuho | Outperform | $43.00 | +54.0% | Reiterated | 2026-09-18 | |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-09-15 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-09-09 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-08-25 |
| — | Needham | Buy | — | — | Reiterated | 2026-08-24 |
| Canaccord Genuity | Buy | $53.00 | +86.0% | Reiterated | 2026-08-20 | |
| Susquehanna | Positive | $51.00 | +79.1% | Reiterated | 2026-08-13 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-08-13 |
| — | UBS | Neutral | — | — | Reiterated | 2026-08-12 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-08-12 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-08-12 |
| Mizuho | Outperform | $52.00 | +77.3% | Reiterated | 2026-08-12 | |
| Cantor Fitzgerald | Overweight | $53.00 | +84.6% | Reiterated | 2026-08-12 | |
| — | Needham | Buy | — | — | Reiterated | 2026-08-12 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-06-09 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-05-28 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-05-14 |
| Susquehanna | Positive | $57.00 | +51.6% | Reiterated | 2026-05-13 | |
| — | Needham | Buy | — | — | Reiterated | 2026-05-13 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2026-05-13 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-05-13 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-04-10 |
| — | Jefferies | Buy | — | — | Reiterated | 2026-04-06 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2026-03-26 |
| Cantor Fitzgerald | — | $52.00 | +70.4% | — | 2026-02-23 | |
| — | Needham | Buy | — | — | Reiterated | 2026-02-18 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-02-18 |
| Goldman Sachs | — | $35.00 | +11.7% | — | 2026-01-20 | |
| Mizuho | Outperform | $60.00 | +91.9% | Reiterated | 2026-01-16 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-01-14 |
| Cantor Fitzgerald | Overweight | $50.00 | +58.1% | Reiterated | 2026-01-12 | |
| — | UBS | Neutral | — | — | Reiterated | 2025-11-12 |
| Susquehanna | Positive | $55.00 | +33.4% | Upgraded | 2025-11-12 | |
| — | Citigroup | Neutral | — | — | Reiterated | 2025-11-11 |
| — | Needham | Buy | — | — | Reiterated | 2025-11-11 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2025-11-11 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-11-11 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-10-14 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-10-03 |
| Mizuho | Outperform | $65.00 | +57.5% | Reiterated | 2025-10-01 | |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-09-11 |
| — | Citigroup | Neutral | — | — | Reiterated | 2025-09-05 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-08-18 |
| UBS | Neutral | $58.00 | +24.0% | Reiterated | 2025-08-14 | |
| — | Citigroup | Neutral | — | — | Reiterated | 2025-08-13 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-08-13 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2025-08-13 |
| — | Needham | Buy | — | — | Reiterated | 2025-08-13 |
| Deutsche Bank | — | $53.00 | +7.6% | — | 2025-08-13 | |
| Mizuho Securities | — | $80.00 | +58.1% | — | 2025-08-12 | |
| Jefferies | — | $80.00 | +57.9% | — | 2025-08-12 | |
| — | Susquehanna | Neutral | — | — | Reiterated | 2025-07-18 |
ETOR earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-17 | 0.65 | 0.71 | $218.3M | $226.8M |
| 2026-05-12 | 0.65 | 0.91 | $234.8M | $258.0M |
| 2026-08-11 | 0.61 | 0.58 | $225.5M | $229.0M |
| 2026-11-10 | 0.30 | 0.00 | $189.4M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.